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Background: The association between smoking and asthma remains unclear and has mostly
been assessed in cross-sectional studies, with potential selection bias (“healthy smoker
effect”).
Aims: Using a longitudinal approach, the aims were to assess whether 1) childhood asthma
modifies smoking initiation, 2) active smoking influences asthma incidence in adults and 3)
active smoking among subjects with asthma influences the persistence of the disease or the
12-year evolution in lung function in children and adults.
Methods: Subjects (513 children and 1190 adults) were recruited and followed-up for 12 years
in the context of the EGEA study (Epidemiological study on the Genetics and Environment of
Asthma).
Results: Childhood asthma was not associated with a decreased probability of starting active
smoking (Hazard Ratio, HRZ 0.96; 95% confidence interval (CI): 0.72, 1.27). Smoking at base-
line was associated with a higher risk for asthma incidence in adulthood (HR Z 1.95, 95% CI:
1.00, 3.77). Among subjects with asthma, smoking was unrelated to lung function evolution;
however, among children with moderate to severe asthma at inclusion, smoking tended to slow
down the lung function growth (P Z 0.04).765 494 00; fax: þ33 04 765 494 13.
-grenoble.fr (L. Vignoud).
1 Published by Elsevier Ltd.
1806 L. Vignoud et al.Conclusion: These findings support the hypothesis that childhood asthma does not prevent
smoking initiation and confirm that active smoking has a deleterious role on asthma. Alto-
gether this study emphasizes the importance of active smoking as a serious public health
problem particularly for children and women.
ª 2011 Published by Elsevier Ltd.Background
The role of environmental tabacco smoke on respiratory
health is a current concern in public health.1 Although
active smoking is recognized as the most important risk
factor for the development of chronic obstructive pulmo-
nary disease2 the complex association between asthma
and active smoking remains unclear. Active smoking is
surprisingly common in individuals with asthma.3 While
one might expect that individuals with asthma would avoid
smoking, previous cross-sectional studies reported no
difference in smoking between individuals with and
without asthma4,5 and in one caseecontrol study it was
even observed that individuals with asthma were more
often smokers.6 Few longitudinal studies with children
followed up to adulthood and with data on asthma severity
focused on this association.7 Furthermore, one could
hypothesize that medical advices aimed at preventing
subjects with asthma from smoking and the evolution of
asthma management might have led to different obser-
vations in more recent studies.
Another aspect of the relation between smoking and
asthma concerns the role of active smoking on asthma
incidence, which remains controversial.5,8,9 Some studies
suggested a rather complex association by indicating that
other factors, e.g. sex, age and allergy may modify this
association.10e12 Among individuals with asthma, indica-
tions that active smoking increases asthma severity,5,13
accelerates decline in lung function,14,15 impairs thera-
peutic response to corticosteroids16 and worsens/weakens
asthma control17,18 have been reported. However results in
the follow-up of the European Community Respiratory
Health Survey (ECRHS II) did not support a role of smoking in
lung function decline in young adults with asthma19;
moreover, smoking was not associated with uncontrolled
asthma in the follow-up of the Epidemiological Study on the
Genetics and Environment in Asthma (EGEA2).20
The relationship between smoking and asthma remains
difficult to address, particularly in cross-sectional studies,
because of the potential selection bias toward smoking, the
so-called “healthy smoker effect”.21 Prospective studies
with lifetime smoking are more able to properly examine
the relationships between smoking and asthma.
The 12-year follow-up of the EGEA study, including
2047 children and adults at baseline, offers for the first
time the opportunity to simultaneously address three
important aspects regarding the mutual influences
between smoking and asthma: 1) the role of childhood-
onset asthma in smoking initiation, 2) the role of active
smoking in asthma incidence in adulthood and 3) the role
of active smoking in the persistence of asthma and in the
12-year evolution of lung function both in children and
adults.Methods
Population
EGEA is a cohort study based on an initial group of asthma
cases, first-degree relatives of cases, and controls
followed-up over 12 year. The subjects participated twice,
between 1991 and 1995 in the first survey (EGEA1) and
between 2003 and 2007 in the follow-up (EGEA2). In EGEA1,
388 children and adult cases with asthma, recruited in five
chest clinics, 1244 first-degree relatives of cases and 415
population-based controls were enrolled (nZ 2047).22,23 In
the frame of the 12-year follow-up, EGEA2, a self-
completed questionnaire was returned by 1921 subjects
(92.2% of the alive cohort and 58 new family members) and
detailed information were available for 1601 subjects who
participated to a complete examination (77.1% of the alive
cohort and 58 new family members).20 The examination
included detailed questionnaires, assessment of total
serum IgE, lung function tests (spirometry and methacho-
line challenge test), and skin prick test to 11 aero-
allergens. Sensitization was defined by the presence of
a positive skin prick test (SPT) (mean wheal diame-
ter  3 mm) to at least one of 11 aero-allergens. Consent
was obtained from all participants at both surveys. Ethical
approval to carry out the study was obtained for both
surveys from the relevant committees (Cochin Royal
Hospital, Paris for EGEA1 and Necker-Enfants Malades
Hospital, Paris for EGEA2).
Specific sub-populations (Fig. 1) were identified to
address each question. The role of childhood-onset asthma
in smoking initiation was addressed in 513 subjects younger
than 17 years at inclusion. The role of active smoking in
asthma incidence was assessed among 812 adults without
asthma at baseline. The role of active smoking in the
persistence of asthma and in the 12-year evolution in the
lung function was addressed among 245 children and 378
adults with asthma at baseline (Fig. 1).
Phenotypes
Individuals with ever asthma were those recruited as
asthmatic cases in chest clinics or answering positively to
one of the two following questions “Have you ever had
asthma attacks?”, “Have you ever had attacks of breath-
lessness at rest with wheezing?”. Subjects with ever asthma
were defined as having active asthma if they reported in
the 12 months before inclusion or follow-up either at least
one asthma attack or the use of any treatment against
asthma or to help breathing. Subjects with persistent
active asthma were those with active asthma both at
baseline and at follow-up. The severity of asthma at EGEA1
Figure 1 Flow chart of the selected populations for the three aims of the study.
Asthma and smoking 1807(mild vs moderate/severe) was defined with data available
in the study, following the principle of the GINA guidelines
by combining the clinical features of the subjects (asthma
attacks frequency, level of symptoms between asthma
attacks, hospitalization for asthma over the past 12
months) and of the type of asthma treatment used in the
past 12 months (none, other than inhaled corticosteroids
(ICS), ICS).24 The asthma symptoms score used consisted of
a sum of the positive answers to 5 questions: wheeze and
breathless, waking up with a feeling of chest tightness,
attack of shortness of breath at rest, attack of shortness of
breath after exercise and waking up by attack of shortness
of breath during the last 12 months.25 Lung function was
assessed using FEV1 (Forced Expiratory Volume in 1 s)
measured by spirometry. FEV1 % predicted was computed
by using reference values from Stanojevic et al,.26 Lung
function change was computed by the difference in FEV1
% predicted between baseline and follow-up divided by the
time of follow-up.Smoking information
At both surveys, current smokers were defined as subjects
who reported smoking at least one cigarette per day for at
least one year and did not report to have stopped smoking
when they were interviewed. Former smokers were
subjects who smoked daily and had given up for at least 1month before the survey. Never smokers were those
reporting to have never smoked. The daily consumption of
tobacco was evaluated, considering one cigarette, one
cigarillo and one cigar corresponding to 1, 2 and 5g of
tobacco, respectively. Cumulative consumption was
computed taking into account current consumption and
smoking habits in two preceding periods in cases of change.
Twenty-seven subjects who reported ever smoking at
EGEA1 but never smoking at EGEA2 were considered ex-
smokers at EGEA2. Eighteen subjects who reported never
smoking at EGEA1 and smoking at EGEA2 with an age at
smoking initiation at EGEA2 younger than their age at
EGEA1 were excluded from the entire study population.Statistical analysis
To assess the role of asthma in smoking initiation, a Cox
proportional hazard regression model was applied in which
asthma at baseline was the risk factor under study and
smoking initiation during the follow-up was the event (date
of smoking onset collected at EGEA2). The Cox model was
stratified by age at baseline (<12 years, 12 years) to take
into account the heterogeneity of the risk of smoking
initiation according to the age of the subjects at baseline
and adjusted for sex, age, 1 smoker in the household,
paternal socio-economic status and center. children who
reported to smoke at baseline were excluded (n Z 12).
1808 L. Vignoud et al.A sensitivity analysis was conducted, restricted to subjects
with asthma recruited as cases (nZ 156), a population with
a more specific asthma phenotype, including more
moderate/severe asthma at baseline.
To assess the role of smoking as a risk factor for asthma,
a Cox regression model was applied in which smoking
status at baseline was the risk factor and asthma incidence
during the follow-up was the event. To take into account
the uncertainty of the retrospective report of the age at
asthma onset, the actuarial (discrete time) method was
used (survival time in 5 periods of 3 years were considered
here: [0e3yrs], [3e6yrs], [6e9yrs], [9e12yrs], [12e15yrs]).
In a sensitivity analysis, the continuous Cox model using
the exact time of the report of the events was used,
leading to similar results. The analysis was stratified by age
in 3 classes (<30, 30-45, >45) to take into account
a potential different association between age groups, and
adjusted for sex, age, socio-economic status, rhinitis and
sensitization to allergens. Two sensitivity analyses were
performed, one after exclusion of subjects with respiratory
symptoms at baseline (asthma symptom score > 1,
n Z 52), the other after exclusion of 3 subjects with
incident asthma and potentially undiagnosed COPD at
follow-up (according to the lower limit of normal (LLN) of
FEV1/FVC ratio).
Logistic and linear regression models were respectively
used to address the role of smoking at baseline in the
persistence of active asthma and in the evolution of lung
function during follow-up. Because part of the population
did not complete the clinical examination at follow-up
but filled-in a detailed self-completed questionnaire, the
analysis on lung function evolution was conducted on
a smaller sample size (n Z 308 adults and 245 children).
Analyses regarding asthma persistence were adjusted for
baseline factors: age, sex, center, socio economic status
(at EGEA2 for children) and inhaled corticosteroids (ICS)
use in the past 12 months. Analysis regarding FEV1% pred
were adjusted for the following characteristics at base-
line: age, sex, center, socio economic status (at EGEA2
for children), and the mean FEV1 %pred (to avoid the
interference of regression toward the mean, FEV1 level
during the study was estimated by the average of the
initial and final value (FEV1 % pred at baseline þ FEV1 %
pred at follow-up)/2)). A sensitivity analysis was per-
formed after exclusion of subjects who modified their
smoking habits during the follow-up (see Supplementary
file 1).
All adjusted analyses took into account the familial
dependence between relatives, using random effect for
linear regression, Generalized Estimated Equation for
logistic regression and marginal Cox proportional hazard
regression model for survival analyses. All analyses were
performed using the SAS 9.1 statistical software (SAS
institute, Cary, NC).Results
Both in children and adults, individuals with asthma were
younger than individuals without asthma (Table 1). As
expected, there were more boys than girls with asthma in
children, individuals with asthma had a lower lung functionand were more often sensitized to aero-allergens at base-
line than individuals without asthma (Table 1). As previ-
ously shown in the cross-sectional analysis at EGEA1, adults
with asthma had started smoking as often as those without
asthma, but were more often former smoker at baseline.5
The smoking status of the subjects at baseline and follow-
up are presented in Supplementary file 1.
Role of childhood asthma in smoking initiation
Characteristics of children with asthma (n Z 258) and
without asthma (nZ 255) are described in Table 1. Smoking
initiation during follow-up was similar in children with and
without asthma at baseline (45.4% and 49.0% respectively,
P Z 0.41). Crude survival analysis showed no association
between asthma at baseline and the initiation of smoking
(hazard ratio (HR) Z 0.91, 95% confidence interval (CI):
0.71, 1.16). After adjustment, smoking initiation remained
unrelated to asthma (HR Z 0.96, 95% CI: 0.72, 1.27)
(Fig. 2). Stratification on sex or ETS exposure and dis-
tinguishing different levels of asthma severity did not
reveal associations (Fig. 2). The analysis restricted to
subjects with asthma recruited as cases, a population
which comprised individuals with more moderate/severe
asthma at baseline, led to the same conclusion (HRZ 0.92,
95% CI: 0.65, 1.29).
Role of smoking in asthma incidence
In adults without asthma at baseline, smoking status was
related to sex (more women among never smokers) and age
(older subjects among ex-smokers) (Table 2). Socio-
economic status was associated with smoking behavior.
Asthma incidence was higher among current smokers (9.7%)
compared to never smokers (5.8%) and former smokers
(3.0%). The survival analysis highlighted a higher asthma
incidence in current smokers compared to never and former
smokers (LogeRank test, P Z 0.02). After adjustment for
confounders, the HR of asthma associated to smoking was
1.95 (95% CI: 1.00, 3.77) (Fig. 3). The analysis stratified by
sex showed a trend for a higher risk associated with current
smoking in women compared to men (HR were 2.43, 95% CI:
1.05, 5.63, and 1.32, 95% CI: 0.56, 3.13, respectively)
although the interaction term was not significant (PZ 0.4).
Smoking remained associated with asthma incidence after
exclusion of subjects with respiratory symptoms at base-
line, a population potentially with undiagnosed asthma at
baseline (HR Z 2.48, 95% CI: 1.16, 5.32, P Z 0.02). The
exclusion of 3 subjects with incident asthma and potentially
undiagnosed COPD at follow-up decreased the risk associ-
ated with smoking in the whole population (HRZ 1.65, 95%
CI: 0.83, 3.28), but results remained almost unchanged for
women (HR Z 2.29, 95% CI: 0.96, 5.48, P Z 0.06). The
adjusted HR of asthma tended to increase with the amount
of tobacco smoke assessed with pack-years and smoking
duration (compared to never smokers, HR for asthma inci-
dence were 1.28, 95% CI: 0.64, 2.56 and 1.80, 95% CI: 0.82,
3.93 for smokers with 10 pack-years and >10 pack-years
respectively and 1.17, 95% CI: 0.55, 2.47 and 1.96, 95%
CI: 0.87, 4.43 for smoking duration 15 yrs and >15 yrs
respectively).
Table 1 Baseline characteristics of the three populations selected to address aim 1 (children at baseline, n Z 513), aim2
(adult without asthma, n Z 853) and aim3 (children (n Z 258) and adults (n Z 416) with asthma).
Children at baseline, n Z 513 Adults at baseline, n Z 1269
Without asthma With asthma P* Without asthma With asthma P*
n 255 258 853 416
Age at baseline, m  sd 11.2  3.1 10.8  2.6 0.08 39.8  12.3 37.3  13.4 0.001
Sex, males, (n) % (126) 49.4 (164) 63.6 0.001 (401) 47.0 (212) 51.0 0.19
Age of asthma onset
 4yrs, (n) % e (152) 60.3 e (83) 20.4
4e16yrs, (n) % e (100) 39.7 e (140) 34.4
>16 yrs, (n) % e e e (184) 45.2
FEV1 % predicted at baseline
a,
m  sd Asthma symptoms
score at baselineb
99.6  10.5 97.7  13.4 0.08 100.9  12.5 90.1  18.6 <0.0001
0, (n) % (217) 90.0 (10) 4.3 <0.0001 (558) 70.5 (65) 16.5 <0.0001
1, (n) % (20) 8.3 (28) 11.9 (174) 22.0 (46) 11.7
2, (n) % (3) 1.2 (42) 17.9 (43) 5.4 (55) 14.0
3, (n) % (1) 0.4 (58) 24.7 (14) 1.8 (60) 15.2
4, (n) % (0) 0 (44) 18.7 (2) 0.3 (71) 18.0
5, (n) % (0) 0 (53) 22.6 (0) 0 (97) 24.6
Moderate/severe asthma, (n) % e (66) 29.1 e (150) 42.1
Sensitizationc (n) % (100) 40.7 (215) 86.4 <0.0001 (300) 36.1 (293) 72.9 <0.0001
Smoking status at baseline
Never smokers, (n) % e e (422) 49.7 (210) 51.1 0.08
Former smokers, (n) % e e (206) 24.3 (116) 28.2
Current smokers, (n) % e e (221) 26.0 (85) 20.7
Pack years for ever smokers
10, (n) % e e (217) 53.9 (115) 61.2 0.25
10e20, (n) % e e (95) 23.6 (38) 20.2
>20, (n) % e e (91) 22.6 (35) 18.6
ETS exposure at home, (n) % (117) 46.1 (101) 39.2 0.11 e e
*p value from c2 test for categorical variables and
Student test for continuous variables.
a Based on Stanojevic et al 26.
b As defined by Pekkanen et al 44.
c Wheal  3 mm control for any of 11 allergens.
Figure 2 Hazard ratio of smoking initiation associated with
asthma at baseline. Multivariate analysis was stratified by age
in 2 classes (<12 yrs) and adjusted for sex, age, 1 smoker in
the household, father socio-economic status and center.
Asthma and smoking 1809Role of smoking in asthma persistence and lung
function evolution
In subjects with active asthma at baseline, smoking in
adults (ex-smoking and current smoking at EGEA1) and in
children (initiation of smoking during the follow-up) tended
to be associated with a lower risk of asthma persistence,
but the associations were not statistically significant (see
Supplementary file 2). In adults with asthma at baseline,
the 12-year change in FEV1 was not significantly associated
with smoking status (Table 3). Similar results were observed
in the analysis stratified by asthma severity at baseline and
in adults older than 30 years at baseline (Table 3). The
exclusion of subjects who modified their smoking habits
during the follow-up (see Supplementary file 1) also led to
the same conclusion (data not shown). A further analysis
considering the amount of tobacco smoked (pack-years and
smoking duration) showed no association with change in
FEV1.
The 12-year evolution of FEV1 was similar in children
who started to smoke compared to never smokers (Table
Table 2 Description of the population of adults without asthma at baseline according to the smoking status and crude
association between smoking status and asthma incidence (Aim 2).
Adults without asthma at baseline P*
All individuals
n Z 812
Never
Smokers
n Z 397
Former
smokers
n Z 198
Current
Smokers
n Z 217
Characteristics at baseline
Sex, males, (n) % (381) 46.9 (140) 35.3 (116) 58.6 (125) 57.6 <0.0001
Age, m  sd 39.9  12.3 38.7  13.1 44.9  9.8 37.7  11.7 <0.0001
Age : <30 yrs, (n) % (196) 24.1 (116) 29.2 (15) 7.7 (65) 30.0 <0.0001
[30e45], (n) % (330) 40.6 (148) 37.3 (88) 44.4 (94) 43.3
>45 yrs, (n) % (286) 35.2 (133) 33.5 (95) 48.0 (58) 26.7
Socio-economic status:
- Managers, (n) % (257) 32.3 (109) 28.0 (73) 37.1 (75) 35.9 <0.0001
- Technicians, (n) % (308) 38.7 (162) 41.7 (82) 41.6 (64) 30.6
- Manual workers, (n) % (126) 15.9 (50) 12.9 (33) 16.8 (43) 20.6
- No occupation, (n) % (104) 13.1 (68) 17.5 (9) 4.6 (27) 12.9
Smoking duration, yrs, m  sd e e 13.5  8.7 18.1  10.7 <0.0001
Pack years, m  sd e e 12.1  12.6 13.6  12.0 <0.0001
Allergic rhinitis, (n) % (199) 24.8 (107) 27.3 (48) 24.5 (44) 20.4 0.17
Sensitizationa (n) % (278) 35.1 (130) 33.7 (66) 34.2 (82) 38.5 0.47
Asthma incidence at follow-up, (n) % (50) 6.2 (23) 5.8 (6) 3.0 (21) 9.7 0. 02
*p values from c2 test for categorical variables and ANOVA for continuous variables.
a Wheal  3 mm control for any of 11 allergens.
1810 L. Vignoud et al.4). However, in children with moderate/severe asthma,
smokers tended to have a worse lung function evolution
than never smokers (change in FEV1 % predicted per year
were 0.27  0.24 in smokers and 0.37  0.30 in non-
smokers, P Z 0.04). Similarly, in children treated with
ICS at baseline, change in FEV1 was lower in smokers
compared to never smokers (P Z 0.05), although similar
baseline FEV1 were observed between these two groups
(data not shown).Figure 3 Hazard ratio of asthma incidence associated with
smoking status at baseline. Multivariate analysis was stratified
by age in 3 classes and adjusted for sex, age, socio-economic
status, rhinitis and sensitization.Discussion
The present study, in the 12-year longitudinal EGEA study,
is the first to simultaneously address the role of childhood
asthma in smoking initiation and the role of smoking as
a risk factor for asthma incidence and for impaired lung
function evolution in asthmatics. Our findings support the
hypothesis that asthma status in childhood does not
prevent smoking initiation and confirms that smoking is
a risk factor for asthma in adulthood. In adults with asthma,
smoking did not increase the age-related decline in lung
function. However, our results suggest that among children
with moderate to severe asthma, starting to smoke may
slow down lung function growth.
One of the strengths of the EGEA study is the detailed
phenotypic characterization available over a 12-year
follow-up. The longitudinal design, with both children
and adults at baseline, allows investigating the mutual
associations between smoking and asthma at various ages.
The 12-year follow-up, with a high follow-up rate (self-
completed questionnaire returned for 92% of surviving
patients and re-examination for 77% of patients), allowed
to efficiently assess the relationship between a factor with
a long term effect, such as smoking, and a complex
disease, such as asthma. The design of the study, with
cases recruited in chest clinics at baseline, allows
addressing the role of asthma severity in the association
between smoking and asthma, an issue difficult to address
in population-based studies. Smoking habits were recorded
by a detailed face to face interview which is expected to
minimize the potential under-report of smoking. A partic-
ular effort was addressed to take into consideration all
Table 3 12 year change in FEV1 according to smoking status at baseline in adults with asthma (Aim 3).
Multivariate analysis FEV1 %predicted
at baselinea
FEV1 %predicted
at follow-upa
Change in FEV1 %predicted per
yearb (FEV1 follow-up %pred e
FEV1 _baseline % pred)/follow-up
time
All adults (n Z 308)
Never smokers (n Z 159) 86.4  1.6 85.7  1.7 0.008  0.09
Former smokers (n Z 94) 88.4  2.0 85.9  2.1 0.17  0.12 P Z 0.28
Current smokers (n Z 55) 93.1  2.6 92.0  2.7 0.11  0.16 P Z 0.56
Adults with mild asthma (n Z 157)
Never smokers (n Z 83) 91.1  2.2 89.8  2.4 0.10  0.11
Former smokers (n Z 44) 95.4  2.9 94.3  3.1 0.10  0.15 P Z 0.53
Current smokers(n Z 30) 97.2  3.4 94.2  3.6 0.22  0.17 P Z 0.99
Adults with moderate/severe asthma (n Z 112)
Never smokers (n Z 54) 81.9  2.8 82.6  2.8 0.03  0.21
Former smokers (n Z 39) 82.6  3.0 79.8  3.1 0.17  0.23 P Z 0.50
Current smokers (n Z 19) 89.8  4.6 87.8  4.5 0.05  0.34 P Z 0.96
Adults 30yrs (n Z 212)
Never smokers (n Z 100) 82.9  3.3 81.8  3.4 0.01  0.20
Former smokers (n Z 80) 84.3  3.4 85.3  3.5 0.10  0.20 P Z 0.51
Current smokers (n Z 32) 86.7  4.4 86.4  4.5 0.04  0.26 P Z 0.81
a Adjusted for the following characteristics at baseline: age, sex, center, socio economic status, and taking into account the familial
dependence.
b djusted for the following characteristics at baseline: age, sex, center, socio economic status, and the mean FEV1 %predicted (FEV1 %
pred at baseline þ FEV1 %pred at follow-up)/2), and taking into account the familial dependence.
Asthma and smoking 1811potential confounders. Nevertheless, reported results
should be interpreted in light of some limitations. One is
the nature of the studied population which is not repre-
sentative of the general population with a higher preva-
lence of moderate to severe asthma at baseline. We should
also recognize that the sample size is limited, particularly
to accurately quantify the impact of smoking on asthma
incidence.
We found no evidence that children with asthma selec-
tively avoid smoking, even after controlling for factorsTable 4 12 year change in FEV1 and smoking status in children
Multivariate analysis FEV1 %predicted
at baselinea
All children (n Z 171)
Never smoker (n Z 98) 99.9  2.0
Start smoking (n Z 73) 96.6  2.0
Children with mild asthma (n Z 114)
Never smoker (n Z 63) 102.9  2.7
Start smoking (n Z 51) 99.2  2.5
Children with moderate/severe asthma (n Z 44)c
Never smoker (n Z 24) 100.9  4.0
Start smoking (n Z 20) 97.7  3.4
a djusted for the following characteristics at baseline: age, sex, cent
familial dependence.
b djusted for the following characteristics at baseline: age, sex, cen
(FEV1 % pred at baseline þ FEV1 %pred at follow-up)/2) and taking in
c Because convergence in the mixed model was not possible due to o
in each of the two families was excluded, and a model without familrelated to the risk of smoking (parental smoking) and taking
into account baseline asthma severity. The previous cross-
sectional analysis conducted in adult cases and controls at
EGEA1, also concluded that asthma does not prevent from
smoking.5 Our conclusion was also shared by several earlier
studies.4,27 To our knowledge, no study showed evidence
for a role of asthma in the reduction of smoking initiation.
On the contrary, and surprisingly, several studies have
observed that adolescents with asthma have even an
increased risk to become smokers.6,28e30 The presentwith asthma (Aim 3).
FEV1 %predicted
at follow-upa
Change in FEV1 %predicted per
yearb (FEV1 at follow-up %pred e
FEV1 _baseline % pred)/follow-up
time
98.3  1.7 0.07  0.15
95.3  1.7 0.15  0.15, P Z 0.59
98.4  2.3 0.33  0.21
97.0  2.1 0.18  0.20, P Z 0.43
103.8  3.4 0.37  0.30
94.5  2.9 0.27  0.24, P Z 0.04
er, on socio economic status at Egea2, and taking into account the
ter, on socio economic status at Egea2, on mean FEV1% predicted
to account the familial dependence.
nly two families with two relatives, one subject chosen at random
ial dependence was conducted.
1812 L. Vignoud et al.longitudinal analysis adds to the evidence that asthma,
nowadays, is still not a powerful motivation to prevent from
smoking initiation.
Our results support a role for smoking in the incidence of
asthma. The role of active smoking in the development of
asthma is debated. Before the 2000’s, most studies indi-
cated that smoking was not related to the incidence of the
disease.31 However, most of the recent studies, both cross-
sectional8,12 and longitudinal,9,11,32e34 indicate that active
smoking is associated with the development of asthma. In
the analysis performed at EGEA1, the lack of association
between active smoking and asthma could be explained by
the cross-sectional design, with a potential under-report of
the smoking habits in cases with asthma at the time they
were recruited in chest clinics, compared to controls.5
Similar results to those reported here were observed
among subjects without asthma symptoms at baseline,
indicating that our findings are unlikely due to a role of
smoking aggravating pre-existing asthma. Although not
significant, the increased risk of asthma incidence with the
increased amount or duration of smoking is suggestive of
a doseeresponse relationship, which is consistent with our
hypothesis. Furthermore, asthma was defined from a clin-
ical diagnosis and not from respiratory symptoms such as
wheezing, known to be associated with smoking. Our find-
ings tend to indicate a greater risk for asthma associated
with smoking in women compared to men. In women, the
risk was unchanged after excluding incident cases with
airway obstruction, making unlikely that the smoking-COPD
association could explain our findings. Three previous
studies also suggest that women could be at higher risk of
asthma when smoking8,35,36 but it remains unknown
whether this observation is related to gender physiological/
biological or sociological differences. Gender differences
were observed in the association between asthma and
higher nicotine addiction levels in current smokers with
higher risk observed in women.37Our results should not be
generalized to the general population, as most of the
incident cases are relatives of individuals with asthma
recruited in chest clinics 12 years earlier, and could
therefore be more prone to develop asthma secondary to
the harmful effects of smoking. Altogether, although our
results should be interpreted cautiously because of the
limited number of incident cases, they are in agreement
with recent data in the literature indicating a deleterious
role of smoking in asthma incidence in adulthood.
Our results on adults with asthma do not suggest a role
of smoking in the persistence of the disease, nor on an
accelerated decline in lung function. The role of current
smoking in the aggravation of asthma is debated. Several
studies observed that smokers with asthma have more
severe symptoms, and worse asthma control than non-
smokers.5,17,18,38 Among patients with asthma, smoking has
been shown to increase health resources utilization,39 and
to impair the efficacy of short-term inhaled corticosteroid
treatment.16 Lange at al showed that combination of
cigarette smoking and asthma led to an accelerated decline
in lung function.14 However, several other studies did not
observe an effect of smoking on FEV1
5,17 or on FEV1
decline19,40 in subjects with asthma. This may be explained
by a healthy smoker effect, supported by a tendency for
a negative relationship between smoking and thepersistence of asthma in our study. Moreover, changes over
time in the behavior of smoking (blond vs brown tabacco,
filters vs no filters) and the evolution in asthma manage-
ment over time may also have led to a lower impact of
smoking on lung function in more recent studies. Our
results suggest that among children with moderate to
severe asthma at baseline, smoking could slow down lung
function growth. This result is in agreement with the
harmful effect of exposure to maternal smoking and ETS
exposure, showed to be associated with asthma incidence
and persistent deficits in lung function of children with
asthma.41,42 This result is also in line with a longitudinal
study of children recruited with severe asthma, showing
that quitting smoking was associated with a smaller annual
FEV1 decline.
43
Conclusions
In conclusion, our findings support the hypothesis that
asthma status in childhood does not prevent smoking initi-
ation and confirms that smoking is a risk factor for asthma
in adulthood. The present study emphasizes that cigarette
smoking constitutes an important preventable public health
problem particularly for women and children. Health care
providers have a central role to play to prevent teenagers
with asthma from starting to smoke.
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